Skip to main content
. 2013 Aug 14;8(8):e71266. doi: 10.1371/journal.pone.0071266

Figure 6. K562/ABCB1 and K562/ABCG2 cells exhibit collateral sensitivity to.

Figure 6

quizartinib. K562, K562/ABCB1 and K562/ABCG2 cells were plated in the presence of quizartinib in increasing concentrations for 96 hours and viable cells were measured using the WST-1 assay.